If you enjoy this content, please share it with a colleague
RELATED CONTENT
December 12, 2023 — Koning Health, a leader in innovative breast imaging technology, announced its participation at the ...
November 1, 2021 — Koning begins an FDA screening trial this month for their no-compression, Isotropic, 3-dimensional ...
October 31, 2017 — Koning Corp. announced it will showcase its Koning Breast CT (computed tomography) system at the 2017 ...
Computed tomography (CT) has evolved significantly since its debut in the 1970s. While the basic principles have stayed the same, manufacturers have been able to expand on these principles to offer enhanced performance and image quality, as ITN contributing editor Greg Freiherr discovered during the 2015 Radiological Society of North America (RSNA) annual meeting, Nov. 29-Dec. 3 in Chicago.
Koning Corp. announced the first commercially available 3-D breast computed tomography (CT) scanner that overcomes the current limitations in 2-D diagnostic mammography. Koning’s technology, the Koning Breast Computed Tomography (KBCT) system, eliminates overlapping tissue concerns and addresses a common patient complaint – breast compression.
The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) market clearance for the Koning Breast CT (KBCT 1000). It is a dedicated breast imaging system that acquires computed tomography (CT) images without compressing the breast. The KBCT produces 3-D images to aid in the diagnosis of breast cancer.
According to a new market research report "Breast Imaging Technologies Market (Digital Mammography,3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) Technology and Market Analysis & Global Forecasts to 2017" is an attempt to showcase the market impact of current and emerging breast imaging technologies having excellent growth potential in the coming five years. The technologies profiled in the report are segmented into Ionizing breast imaging modalities and Non-Ionizing breast imaging technologies on basis of radiation. Ionizing breast imaging modalities include Mammography, 3D Breast Tomosynthesis, Cone beam Computed Tomography (CBCT), Positron Emission Mammography (PEM), Molecular Breast Imaging (MBI), Positron Emission Tomography (PET) and Breast Specific Gamma Imaging (BSGI). The various Non-ionizing modalities for breast screening covered in the report are Breast MRI, Optical Imaging, Breast thermography and Breast Ultrasound.
March 2, 2012 — Koning Corp. a developer of cone beam computed tomography (CBCT) announced that they obtained CE mark approval for their Koning Breast CT (KBCT) system.